Drugs available through the Farmácia Dose Certa program and Beers criteria: a further analysis

Medicamentos disponíveis no programa Farmácia Dose Certa e critérios de Beers: uma análise adicional

Márcio Galvão Oliveira Welma Wildes Amorim Luiz Carlos Passos About the authors

LETTER TO THE EDITOR

Drugs available through the Farmácia Dose Certa program and Beers criteria: a further analysis

Medicamentos disponíveis no programa Farmácia Dose Certa e critérios de Beers: uma análise adicional

Márcio Galvão OliveiraI; Welma Wildes AmorimII; Luiz Carlos PassosIII

IBPharm, MSc. Assistant Professor of Clinical Pharmacy, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia (UFBA), Vitória da Conquista, Bahia, Brazil

IIMD. Geriatrics Specialist, Professor of Internal Medicine, Department of Natural Sciences, Universidade Estadual do Sudoeste da Bahia (UESB), Vitória da Conquista, Bahia, Brazil

IIIMD, PhD. Adjunct Professor of Internal Medicine, Department of Internal Medicine, Faculdade de Medicina da Bahia (FAMEB), Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil

Address for correspondence

Dear Editor,

We read the recently published article by Lucchetti et al.1 and we have an important comment to make on this study. The objective was to assess the drugs in the Farmácia Dose Certa ("Right Dose Pharmacy") program that were considered to be inappropriate for the elderly. The authors used the criteria developed by Beers and updated by Fick in 2003 to assess the appropriateness of drug use among elderly people.2 As described by the authors, the Beers-Fick criteria are divided as follows: (1) drugs or drug classes that should generally be avoided for people over 65 years of age, because they are ineffective or have a high risk of unnecessary adverse effects when a safer alternative is available; and (2) medications that should not be used for elderly patients with specific known conditions. However, only those medicines listed in the first group of Beers-Fick criteria were compared with the available drugs within the Dose Certa program. This underestimates the quantity of potentially inappropriate medications for older people available through this program. One example of this is that metoclopramide should be avoided among patients with Parkinson's disease because of its antidopaminergic/cholinergic effects,2 but was not included in the analysis by Lucchetti et al.1

In our view, the main contribution of their study is to disseminate information about the medications that can potentially be considered inappropriate, and serve as a reference in daily clinical practice. In addition, this information may provide support for regional or national pharmacy and therapeutics committees in making choices of therapeutic alternatives that are more cost-effective and safer for the elderly population.

  • Address for correspondence:
    Márcio Galvão Oliveira
    Universidade Federal da Bahia
    Campus Anísio Teixeira — Instituto Multidisciplinar em Saúde
    Rua Rio de Contas, 58 — Quadra 17 — Lote 58
    Candeias — Vitória da Conquista (BA) — Brasil
    CEP 45029-094
    Tel. (+55 77) 3429-2709
    E-mail:
  • Sources of funding: None

    Conflict of interest: None

    Date of first submission: October 20, 2011

    Last received: December 2, 2011

    Accepted: November 19, 2011

    • 1. Lucchetti G, Lucchetti AL, Pires SL, Gorzoni ML. Beers-Fick criteria and drugs available through the Farmácia Dose Certa program [Critérios de Beers-Fick e medicamentos disponíveis no Programa Farmácia Dose Certa]. Sao Paulo Med J. 2011;129(1):17-22.
    • 2. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24.

    Address for correspondence: Márcio Galvão Oliveira Universidade Federal da Bahia Campus Anísio Teixeira — Instituto Multidisciplinar em Saúde Rua Rio de Contas, 58 — Quadra 17 — Lote 58 Candeias — Vitória da Conquista (BA) — Brasil CEP 45029-094 Tel. (+55 77) 3429-2709 E-mail: mgalvao@ufba.br

    Publication Dates

    • Publication in this collection
      04 Sept 2012
    • Date of issue
      2012
    Associação Paulista de Medicina - APM APM / Publicações Científicas, Av. Brigadeiro Luís Antonio, 278 - 7º and., 01318-901 São Paulo SP - Brazil, Tel.: +55 11 3188-4310 / 3188-4311, Fax: +55 11 3188-4255 - São Paulo - SP - Brazil
    E-mail: revistas@apm.org.br